Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OTHER LIABILITIES
Other Liabilities HALO - Halozyme Therapeutics, Inc.
54.8 M
LAST VALUE
103.53%
2 YEAR CAGR
3429.31%
5 YEAR CAGR
32.98%
10 YEAR CAGR